Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer

NCT05115786 is registered in ClinicalTrials.gov with HBI Solutions Inc. as lead sponsor.

NCT NCT05115786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05115786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
Lead sponsor
HBI Solutions Inc.
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2023
Completion date
December 31, 2024
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer